Topoisomerase I inhibitors: topotecan and irenotecan

Cancer Treat Rev. 1994 Jan;20(1):73-96. doi: 10.1016/0305-7372(94)90011-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Camptothecin / analogs & derivatives*
  • Camptothecin / pharmacokinetics
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use
  • Combined Modality Therapy
  • Drug Resistance
  • Humans
  • Irinotecan
  • Neoplasms / drug therapy
  • Topoisomerase I Inhibitors*
  • Topotecan

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Topoisomerase I Inhibitors
  • Irinotecan
  • Topotecan
  • Camptothecin